Endovision developed a new bio-material KIOMER M3 with superior effects than existing materials by using our own Endoplantech complex technology.
Endovision KIOMER M3 (endoplantech complex technology) is superior to existing chitosan hemostatic products in all functions such as hemostasis, antibacterial, deodorization, absorption, and wetting.
Development
- Possession of core new technology
- R&D network idea discovery
- Securing domestic and overseas certifications and intellectual property rights
- Product commercialization technology transfer
Production
- Manufacturing infra equipped
- Stability through continuous quality control
- Own design and production technology
- Global Standard Quality Control
Distribution
- Increasing the domestic market share
- Expanding into the new overseas market
- Building the expert network
News & Event
We provide the latest news on Endovision,
clinical results, papers, and patents.
Partners
Endovision collaborates with numerous hospitals, universities,
pharmaceutical companies, and biotech firms both domestically
and internationally to provide high-quality products and services.
